During the past decade, Polikliniek Longziekten conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Polikliniek Longziekten" are "Asthma" (1 trials) and "Pulmonary Disease, Chronic Obstructive" (1 trials). Many other conditions were trialed in "Polikliniek Longziekten" in a lesser frequency.

Most popular intervention types in "Polikliniek Longziekten" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Reference: Salmeterol MDI 50 µg (2 puffs of 25 µg each) b.i.d., plus fluticasone propionate MDI 500 µg (2 puffs of 250 µg each) b.i.d." (1 trials), "Test: Tiotropium 18 µg per day (one inhalation capsule) plus 12 µg formoterol twice daily (two times one inhalation capsule)" (1 trials), "placebo" (1 trials) and "tiotropium" (1 trials). Other intervention names were less common.

The vast majority of trials in "Polikliniek Longziekten" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Polikliniek Longziekten". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Polikliniek Longziekten, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Polikliniek Longziekten, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".